SCHEMBL6316113

SCHEMBL6316113

Cc1cc(Cl)c(C(=O)C(=CNc2ccccc2)Nc2ccccc2)c(Cl)n1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.44
CYP1A2 P05177 1/20 0.44
SMN1; SMN2 Q16637 4/20 0.43
ALDH1A1 P00352 4/20 0.40
MAPK1 P28482 1/20 0.40
GAA P10253 1/20 0.40
TSHR P16473 1/20 0.40
POLB P06746 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.39
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
HTT P42858 1/20 0.38
RAB9A P51151 4/20 0.37
NPC1 O15118 2/20 0.37
PKM P14618 1/20 0.37
LMNA P02545 1/20 0.36
USP2 O75604 1/20 0.36
GBA1 P04062 1/20 0.36
PTGS2 P35354 1/20 0.36
OPRK1 P41145 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5872276 0.77 SMN1; SMN2 (0.45) KDM4ECYP1A2SMN1; SMN2ALDH1A1MAPK1
SCHEMBL30593189 0.68 SMN1; SMN2 (0.75) SMN1; SMN2ALDH1A1MAPK1POLBL3MBTL1
SCHEMBL3227278 0.68 SMN1; SMN2 (0.75) SMN1; SMN2ALDH1A1MAPK1POLBL3MBTL1
SCHEMBL2630833 0.67 ALDH1A1 (0.53) KDM4ESMN1; SMN2ALDH1A1MAPK1TSHR
SCHEMBL19212155 0.67 POLB (0.76) KDM4ECYP1A2SMN1; SMN2ALDH1A1MAPK1
SCHEMBL11560282 0.65 PCTP (0.54) SMN1; SMN2ALDH1A1POLBMEN1KMT2A
SCHEMBL6031540 0.65 SMN1; SMN2 (0.58) SMN1; SMN2ALDH1A1MAPK1POLBL3MBTL1
SCHEMBL7706726 0.65 SMN1; SMN2 (0.58) KDM4ESMN1; SMN2ALDH1A1MAPK1GAA
SCHEMBL31171378 0.64 HTT (0.52) KDM4ECYP1A2SMN1; SMN2ALDH1A1MAPK1
SCHEMBL27803856 0.63 SMN1; SMN2 (0.59) SMN1; SMN2ALDH1A1MAPK1POLBMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6900205-B2 1,8-Naphthyridine derivatives and their use to treat diabetes and related disorders BAYER PHARMACEUTICALS CORPORATION (US) 2005-05-31 US disclosed